HomeCompareWWHC vs MRK

WWHC vs MRK: Dividend Comparison 2026

WWHC yields 250.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WWHC wins by $460.84M in total portfolio value
10 years
WWHC
WWHC
● Live price
250.00%
Share price
$0.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$460.90M
Annual income
$257,938,329.48
Full WWHC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WWHC vs MRK

📍 WWHC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWWHCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WWHC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WWHC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WWHC
Annual income on $10K today (after 15% tax)
$21,250.00/yr
After 10yr DRIP, annual income (after tax)
$219,247,580.06/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, WWHC beats the other by $219,239,251.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WWHC + MRK for your $10,000?

WWHC: 50%MRK: 50%
100% MRK50/50100% WWHC
Portfolio after 10yr
$230.48M
Annual income
$128,974,063.81/yr
Blended yield
55.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WWHC
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WWHC buys
0
MRK buys
0
No recent congressional trades found for WWHC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWWHCMRK
Forward yield250.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$460.90M$56.8K
Annual income after 10y$257,938,329.48$9,798.13
Total dividends collected$439.24M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WWHC vs MRK ($10,000, DRIP)

YearWWHC PortfolioWWHC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$35,700$25,000.00$11,206$366.19+$24.5KWWHC
2$121,610$83,411.21$12,650$502.35+$109.0KWWHC
3$395,671$265,547.68$14,407$694.19+$381.3KWWHC
4$1,230,830$807,462.69$16,585$967.82+$1.21MWWHC
5$3,664,475$2,347,486.25$19,342$1,363.89+$3.65MWWHC
6$10,452,787$6,531,799.39$22,913$1,947.19+$10.43MWWHC
7$28,597,316$17,412,833.72$27,662$2,823.89+$28.57MWWHC
8$75,121,556$44,522,427.99$34,159$4,173.35+$75.09MWWHC
9$189,683,639$109,303,574.11$43,337$6,308.80+$189.64MWWHC
10$460,899,823$257,938,329.48$56,776$9,798.13+$460.84MWWHC

WWHC vs MRK: Complete Analysis 2026

WWHCStock

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.

Full WWHC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WWHC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WWHC vs SCHDWWHC vs JEPIWWHC vs OWWHC vs KOWWHC vs MAINWWHC vs JNJWWHC vs ABBVWWHC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.